Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, immunogenicity, and clinical
effects of AMG 811 following single subcutaneous dose administration in subjects with
moderate to severe psoriasis.